Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Former FDA Lawyers: Reinstate $500,000 In Approps To Chief Counsel's Office

This article was originally published in The Pink Sheet Daily

Executive Summary

Five former top agency lawyers say filing of amicus briefs in product liability cases is a longstanding practice that predates current Chief Counsel Dan Troy. Rep. Hinchey's justification for shifting $500,000 out of the chief counsel's budget "cannot be supported," the lawyers tell Congress.
Advertisement

Related Content

Final Rx Labeling Rule Should Not Preempt State Product Liability Laws, States Say
Final Rx Labeling Rule Should Not Preempt State Product Liability Laws, States Say
Senate, House Committee Chairmen Come To FDA Chief Counsel Troy’s Defense
Senate, House Committee Chairmen Come To FDA Chief Counsel Troy’s Defense
FDA Approps Amendment Targets Chief Counsel Troy; Pfizer Ties Challenged
FDA Approps Amendment Targets Chief Counsel Troy; Pfizer Ties Challenged

Topics

Advertisement
UsernamePublicRestriction

Register

PS060028

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel